SCOPUS 정보 검색 플랫폼

Volumn 30, Issue 5, 2011, Pages 685-689

Normalization of serum-free light chains in patients with systemic lupus erythematosus upon rituximab treatment and correlation with biological disease activity

(11) Chiche, L a Cournac, J M a Mancini, J b Bardin, N a Thomas, G a Jean, R a Schleinitz, N a Kaplanski, G a Durand, J M a Boucraut, J a Harle J R a

a HÔPITAL DE LA CONCEPTION (France)

b TIMONE HOSPITAL (France)

Author keywords

B cell depletion; Free light chain; Rituximab; Systemic lupus erythematosus

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RITUXIMAB;

ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; FREE LIGHT CHAIN; HUMAN; KIDNEY FAILURE; LIGHT CHAIN; MALE; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; AUTOIMMUNITY; COMPLEMENT C3; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN M; IMMUNOLOGIC FACTORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79959733511 PISSN: 07703198 EISSN: 14349949 Source Type: Journal
DOI: 10.1007/s10067-010-1674-1 Document Type: Article

Times cited : (29)

References (12)

1
- 0035063345
- Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine
- Bradwell AR, Carr-Smith HD, Mead GP, Tang LX, Showell PJ, Drayson MT, Drew R (2001) Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 47:673-680 (Pubitemid 32275810)
- (2001) Clinical Chemistry , vol.47 , Issue.4 , pp. 673-680
- Bradwell, A.R.¹ Carr-Smith, H.D.² Mead, G.P.³ Tang, L.X.⁴ Showell, P.J.⁵ Drayson, M.T.⁶ Drew, R.⁷

2
- 33846001611
- Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome
- DOI 10.1136/ard.2006.052159
- Gottenberg JE, Aucouturier F, Goetz J, Sordet C, Jahn I, Busson M et al (2007) Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome. Ann Rheum Dis 66:23-27 (Pubitemid 46044856)
- (2007) Annals of the Rheumatic Diseases , vol.66 , Issue.1 , pp. 23-27
- Gottenberg, J.-E.¹ Aucouturier, F.² Goetz, J.³ Sordet, C.⁴ Jahn, I.⁵ Busson, M.⁶ Cayuela, J.-M.⁷ Sibilia, J.⁸ Mariette, X.⁹

3
- 58349119131
- Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders
- Terrier B, Sene D, Saadoun D, Ghillani-Dalbin P, Thibault V, Delluc A et al (2009) Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders. Ann Rheum Dis 68:89-93
- (2009) Ann Rheum Dis , vol.68 , pp. 89-93
- Terrier, B.¹ Sene, D.² Saadoun, D.³ Ghillani-Dalbin, P.⁴ Thibault, V.⁵ Delluc, A.⁶

4
- 79959693478
- Free immunoglobulin light chains in patients with rheumatic diseases
- Hoffman U, Opperman M, Kuchler S, Ventur Y, Teuber W, Michels H et al (2003) Free immunoglobulin light chains in patients with rheumatic diseases. Z Rheumatol 62:Fr40a
- (2003) Z Rheumatol , vol.62
- Hoffman, U.¹ Opperman, M.² Kuchler, S.³ Ventur, Y.⁴ Teuber, W.⁵ Michels, H.⁶

5
- 0036822286
- An open study of B lymphocyte depletion in systemic lupus erythematosus
- DOI 10.1002/art.10541
- Leandro MJ, Edwards JC, Cambridge G, Ehrenstein MR, Isenberg DA (2002) An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthitis Rheum 46:2673-2677 (Pubitemid 36118931)
- (2002) Arthritis and Rheumatism , vol.46 , Issue.10 , pp. 2673-2677
- Leandro, M.J.¹ Edwards, J.C.² Cambridge, G.³ Ehrenstein, M.R.⁴ Isenberg, D.A.⁵

6
- 4043179907
- B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose-escalation trial of rituximab
- DOI 10.1002/art.20430
- Looney RJ, Anolik JH, Campbell D, Felgar RE, Young F, Arend LJ, Sloand JA, Rosenblatt J, Sanz I (2004) B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab. Arthitis Rheum 50:2580-2589 (Pubitemid 39062719)
- (2004) Arthritis and Rheumatism , vol.50 , Issue.8 , pp. 2580-2589
- Looney, R.J.¹ Anolik, J.H.² Campbell, D.³ Felgar, R.E.⁴ Young, F.⁵ Arend, L.J.⁶ Sloand, J.A.⁷ Rosenblatt, J.⁸ Sanz, I.⁹

7
- 33749331884
- Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment
- DOI 10.1002/art.22046
- Smith KGC, Jones RB, Burns SM, Jayne DRW (2006) Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis. Arthitis Rheum 54:2970-2982 (Pubitemid 44497778)
- (2006) Arthritis and Rheumatism , vol.54 , Issue.9 , pp. 2970-2982
- Smith, K.G.C.¹ Jones, R.B.² Burns, S.M.³ Jayne, D.R.W.⁴

8
- 0036720993
- Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: Relative sensitivity for detection of monoclonal light chains
- Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA (2002) Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 48:1437
- (2002) Clin Chem , vol.48 , pp. 1437
- Katzmann, J.A.¹ Clark, R.J.² Abraham, R.S.³ Bryant, S.⁴ Lymp, J.F.⁵ Bradwell, A.R.⁶ Kyle, R.A.⁷

9
- 33845985342
- Free light chains (FLC) of immunoglobulins as parameter resembling disease activity in autoimmune rheumatic diseases
- Urban S, Oppermann M, Reucher SW, Schmolke M, Hoffmann U, Hiefinger-Schindlbeck R, Helmke KH (2004) Free light chains (FLC) of immunoglobulins as parameter resembling disease activity in autoimmune rheumatic diseases. Ann Rheum Dis 63:141a
- (2004) Ann Rheum Dis , vol.63
- Urban, S.¹ Oppermann, M.² Reucher, S.W.³ Schmolke, M.⁴ Hoffmann, U.⁵ Hiefinger-Schindlbeck, R.⁶ Helmke, K.H.⁷

10
- 74849131972
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial
- Merrill JT, Neuwelt CM, Wallace DJ, Shanahan JC, Latinis KM, Oates JC, Utset TO, Gordon C, Isenberg DA, Hsieh HJ, Zhang D, Brunetta PG (2010) Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum 62:222-233
- (2010) Arthritis Rheum , vol.62 , pp. 222-233
- Merrill, J.T.¹ Neuwelt, C.M.² Wallace, D.J.³ Shanahan, J.C.⁴ Latinis, K.M.⁵ Oates, J.C.⁶ Utset, T.O.⁷ Gordon, C.⁸ Isenberg, D.A.⁹ Hsieh, H.J.¹⁰ Zhang, D.¹¹ Brunetta, P.G.¹²

11
- 76049097862
- Baseline autoantibody profiles predict normalization of complement and anti-dsDNA autoantibody levels following rituximab treatment in systemic lupus erythematosus
- Tew GW, Rabbee N, Wolslegel K, Hsieh HJ, Monroe JG, Behrens TW, Brunetta PG, Keir ME (2010) Baseline autoantibody profiles predict normalization of complement and anti-dsDNA autoantibody levels following rituximab treatment in systemic lupus erythematosus. Lupus 19:146-157
- (2010) Lupus , vol.19 , pp. 146-157
- Tew, G.W.¹ Rabbee, N.² Wolslegel, K.³ Hsieh, H.J.⁴ Monroe, J.G.⁵ Behrens, T.W.⁶ Brunetta, P.G.⁷ Keir, M.E.⁸

12
- 78649748637
- Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity
- Kormelink TG, Tekstra J, Thurlings RM, Boumans MH, Vos K, Tak PP, Bijlsma JW, Lafeber FP, Redegeld FA, van Roon JA (2010) Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity. Ann Rheum Dis 69:2137-2144
- (2010) Ann Rheum Dis , vol.69 , pp. 2137-2144
- Kormelink, T.G.¹ Tekstra, J.² Thurlings, R.M.³ Boumans, M.H.⁴ Vos, K.⁵ Tak, P.P.⁶ Bijlsma, J.W.⁷ Lafeber, F.P.⁸ Redegeld, F.A.⁹ Van Roon, J.A.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.